Does a novel `` delayed start '' protocol with gonadotropin-releasing hormone antagonist improve outcomes in poor responders?
The delayed-start protocol improves ovarian response in poor responders by promoting and synchronizing follicle development without impairing oocyte developmental competence.
A dosage of 0.125mg GnRH antagonist protocol was effective for these unselected patients during IVF/ET.